[New molecular-targeted agents for colorectal cancer - regorafenib and aflibercept].

Shunsuke Kato

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of '[New molecular-targeted agents for colorectal cancer - regorafenib and aflibercept].'. Together they form a unique fingerprint.

Medicine & Life Sciences